Paul Kim - Jul 24, 2023 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
Director
Signature
/s/ Kamal Adawi, as attorney-in-fact
Stock symbol
XGN
Transactions as of
Jul 24, 2023
Transactions value $
$0
Form type
4
Date filed
7/26/2023, 04:06 PM
Previous filing
Jun 6, 2023
Next filing
Aug 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XGN Stock Option(right to buy) Award $0 +15K $0.00 15K Jul 24, 2023 Common Stock 15K $2.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is exercisable as it vests. The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on August 24, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date.